Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika

Z. Szekanecz, Gabriella Lakos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: There is a need for highly sensitive and specific laboratory tests for the early diagnosis of rheumatoid arthritis (RA). Anticitrullinated protein/peptide antibodies are produced in the sera of RA patients. Objective: To assess and discuss the diagnostic value of Orgentec antimutated citrullinated vimentin (anti-MCV) ELISA and to compare this diagnostic to commercially available anticyclic citrullinated peptide (anti-CCP) tests. Methods: The evaluation is based on our recently published study on the comparison of anti-MCV and anti-CCP2 tests, as well as on published studies. Results/conclusion: In established RA, the anti-MCV ELISA exerts a specificity comparable with anti-CCP2. Numerous recent studies suggest that anti-MCV may have higher sensitivity, however there are also some publications stating the opposite. In early RA, anti-MCV may be a better predictor of disease activity and radiological progression than anti-CCP tests.

Original languageEnglish
Pages (from-to)1083-1090
Number of pages8
JournalExpert Opinion on Medical Diagnostics
Volume2
Issue number9
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Vimentin
Peptides
Rheumatoid Arthritis
Enzyme-Linked Immunosorbent Assay
Antibodies
Proteins
Publications
Early Diagnosis
Serum

Keywords

  • Anticyclic citrullinated peptide
  • Antimutated citrullinated vimentin
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine(all)
  • Biochemistry, medical
  • Molecular Medicine

Cite this

Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika. / Szekanecz, Z.; Lakos, Gabriella.

In: Expert Opinion on Medical Diagnostics, Vol. 2, No. 9, 09.2008, p. 1083-1090.

Research output: Contribution to journalArticle

@article{19ea580c699b4c8da7a811d235235be2,
title = "Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika",
abstract = "Background: There is a need for highly sensitive and specific laboratory tests for the early diagnosis of rheumatoid arthritis (RA). Anticitrullinated protein/peptide antibodies are produced in the sera of RA patients. Objective: To assess and discuss the diagnostic value of Orgentec antimutated citrullinated vimentin (anti-MCV) ELISA and to compare this diagnostic to commercially available anticyclic citrullinated peptide (anti-CCP) tests. Methods: The evaluation is based on our recently published study on the comparison of anti-MCV and anti-CCP2 tests, as well as on published studies. Results/conclusion: In established RA, the anti-MCV ELISA exerts a specificity comparable with anti-CCP2. Numerous recent studies suggest that anti-MCV may have higher sensitivity, however there are also some publications stating the opposite. In early RA, anti-MCV may be a better predictor of disease activity and radiological progression than anti-CCP tests.",
keywords = "Anticyclic citrullinated peptide, Antimutated citrullinated vimentin, Rheumatoid arthritis",
author = "Z. Szekanecz and Gabriella Lakos",
year = "2008",
month = "9",
doi = "10.1517/17530059.2.9.1083",
language = "English",
volume = "2",
pages = "1083--1090",
journal = "Expert Opinion on Medical Diagnostics",
issn = "1753-0059",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika

AU - Szekanecz, Z.

AU - Lakos, Gabriella

PY - 2008/9

Y1 - 2008/9

N2 - Background: There is a need for highly sensitive and specific laboratory tests for the early diagnosis of rheumatoid arthritis (RA). Anticitrullinated protein/peptide antibodies are produced in the sera of RA patients. Objective: To assess and discuss the diagnostic value of Orgentec antimutated citrullinated vimentin (anti-MCV) ELISA and to compare this diagnostic to commercially available anticyclic citrullinated peptide (anti-CCP) tests. Methods: The evaluation is based on our recently published study on the comparison of anti-MCV and anti-CCP2 tests, as well as on published studies. Results/conclusion: In established RA, the anti-MCV ELISA exerts a specificity comparable with anti-CCP2. Numerous recent studies suggest that anti-MCV may have higher sensitivity, however there are also some publications stating the opposite. In early RA, anti-MCV may be a better predictor of disease activity and radiological progression than anti-CCP tests.

AB - Background: There is a need for highly sensitive and specific laboratory tests for the early diagnosis of rheumatoid arthritis (RA). Anticitrullinated protein/peptide antibodies are produced in the sera of RA patients. Objective: To assess and discuss the diagnostic value of Orgentec antimutated citrullinated vimentin (anti-MCV) ELISA and to compare this diagnostic to commercially available anticyclic citrullinated peptide (anti-CCP) tests. Methods: The evaluation is based on our recently published study on the comparison of anti-MCV and anti-CCP2 tests, as well as on published studies. Results/conclusion: In established RA, the anti-MCV ELISA exerts a specificity comparable with anti-CCP2. Numerous recent studies suggest that anti-MCV may have higher sensitivity, however there are also some publications stating the opposite. In early RA, anti-MCV may be a better predictor of disease activity and radiological progression than anti-CCP tests.

KW - Anticyclic citrullinated peptide

KW - Antimutated citrullinated vimentin

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=77953435957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953435957&partnerID=8YFLogxK

U2 - 10.1517/17530059.2.9.1083

DO - 10.1517/17530059.2.9.1083

M3 - Article

C2 - 23495927

AN - SCOPUS:77953435957

VL - 2

SP - 1083

EP - 1090

JO - Expert Opinion on Medical Diagnostics

JF - Expert Opinion on Medical Diagnostics

SN - 1753-0059

IS - 9

ER -